Cilo Cybin Pharmaceutical, a South African cannabis producer, announced plans to IPO on the Johannesburg Stock Exchange.
The company also announced it will undertake a strategy geared towards the business of psychedelic medicines, by applying for a research permit to study psilocybin, the active compound in so-called “magic mushrooms.”
CEO Gabriel Theron said in an interview with Bloomberg that his company plans a stock listing within the next 12 months. The executive reported that a possible secondary listing in the Luxembourg Stock Exchange, or LuxSE, could follow.
Cilo Cybin received a certification from the South Africa Health Products Regulatory Authority to grow, process and package cannabis products. The company is a holder of one of the 28 licenses granted by the South African government to produce cannabis for commercial purposes.
According to Bloomberg, Cilo Cybin is allowed to export cannabis internationally and “is signing several international deals” for distribution in Australia, Brazil, the UK, parts of Europe and Israel.
The company operates an indoor growing facility that can produce about 100kg (220 lb) of cannabis flower per month.
Photo: Johannesburg, South Africa by Clodagh Da Paixao on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!